Myeloma Trial Results Spark Talk of 'Potential Cure' — One-third of patients alive and progression-free 5 or more years after a single infusion ...

PURPOSEGEMPAX was an open-label, randomized phase III clinical trial designed to assess the efficacy and tolerability of gemcitabine plus paclitaxel versus gemcitabine alone as second-line treatment ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

ASCO 2025 phase 1b/2 study assessing 9MW2821, nectin-4 antibody drug conjugate, toripalimab in treatment-naïve patients, locally advanced or metastatic urothelial carcinoma.

In AERIFY-2, however, itepekimab failed to hit this same threshold, showing only a 2% reduction in exacerbations at 52 weeks. “Sentiment has undoubtedly been poor for REGN shares of late following the ...

Lineage Cell Therapeutics recently announced 36-month results from a phase 1/2a clinical study (NCT02286089) of RG6501 (OpRegen) for the treatment of geographic atrophy (GA), secondary to age-related ...

Regeneron's Dupixent leads growth as Eylea sales decline and valuation is attractive, but growth is delayed by 2-3 years. Learn more on REGN stock here.

Positive results from the confirmatory clinical efficacy and safety study of ADL-018, proposed biosimilar to XOLAIR® The clinical study met its primary endpoint in Chronic Spontaneous Urticaria ...

NEWS 25 June 2025 Does using ChatGPT change your brain activity? Study sparks debate Scientists warn against reading too much into a small experiment generating a lot of buzz.

Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry DiseaseSTAAR study demonstrated positive mean annualized estimated glomerular filtration rate (eGFR ...

Nektar (NKTR) stock more than doubles as its eczema drug hits key targets in Phase 2b trial, promising new biology in autoimmune treatment.

By Connor Hart Shares of Exelixis climbed after the company reported what it called positive topline results from a trail studying a potential treatment for colorectal cancer.